Intellectual Property India Publishes Patent Application for 'Binding Proteins And Engineered Cells Specific For Neoantigens And Uses Thereof' Filed by Affini-T Therapeutics, Inc.; and Fred Hutchinson Cancer Center

MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202417101228 A) filed by Affini-T Therapeutics, Inc.; and Fred Hutchinson Cancer Center, Needham, U.S.A., on Dec. 20, 2024, for 'binding proteins and engineered cells specific for neoantigens and uses thereof.'

Inventor(s) include Shapiro, Gary; He, Xingyue; Drain, Allison; Qu, Hongjing; Hoffmann, Michele; Liang, Jinsheng; Schmitt, Thomas; Martinov, Tijana; Greenberg, Philip; and Perret, Rachel.

The application for the patent was published on March 14, under issue no. 11/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides compositions and methods for targeting a neoantigen to, for example, t...